Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
UNCY
Stock Latest News
The Fly
Unicycive Therapeutics initiated with a Buy at Guggenheim
22d ago
UNCY
Premium
Ratings
Buy Rating for Unicycive Therapeutics: Competitive Advantages of Oxylanthanum Carbonate in Hyperphosphatemia Treatment
1M ago
UNCY
Premium
Ratings
Unicycive Therapeutics: Buy Rating on Imminent FDA Approval and Market Potential of Oxylanthanum Carbonate
1M ago
UNCY
Premium
The Fly
Unicycive presents new patient-level data from Phase 2 study of OLC
1M ago
UNCY
Premium
Ratings
Buy Rating for Unicycive Therapeutics Amid Favorable Risk/Reward and Strategic Growth Opportunities
1M ago
UNCY
Premium
Ratings
Promising Prospects for Unicycive Therapeutics: Buy Rating Backed by Upcoming Milestones and Strategic Preparations
1M ago
UNCY
Premium
The Fly
Unicycive Therapeutics price target raised to $7.50 from $4 at H.C. Wainwright
1M ago
UNCY
Premium
The Fly
Unicycive Therapeutics reports FY24 EPS (56c), consensus (51c)
1M ago
UNCY
Premium
Pre-Earnings
Is UNCY a Buy, Before Earnings?
2M ago
UNCY
Premium
The Fly
Unicycive to present patient reported outcomes data from UNI-OLC-201 study
2M ago
UNCY
Premium
The Fly
Unicycive Therapeutics’ OLC shows synergy with tenapanor in published study
3M ago
UNCY
Premium
The Fly
Unicycive announces publication of patient perspectives on phosphate management
3M ago
UNCY
Premium
The Fly
Unicycive Therapeutics announces publication of OLC dose escalation data
4M ago
UNCY
Premium
The Fly
Unicycive announces puvlication of OLC positive bioequivalence data
5M ago
UNCY
Premium
The Fly
Unicycive Therapeutics price target raised to $4 from $2.50 at H.C. Wainwright
6M ago
UNCY
Premium
The Fly
Unicycive Therapeutics files $100M mixed securities shelf
6M ago
UNCY
Premium
The Fly
Unicycive Therapeutics reports Q3 EPS (13c), consensus (15c)
6M ago
UNCY
Premium
The Fly
Unicycive Therapeutics expects cash to fund operations into 2026
6M ago
UNCY
Premium
The Fly
Unicycive Therapeutics announces U.S. FDA acceptane for NDA for OLC
6M ago
UNCY
Premium
Pre-Earnings
UNCY Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6M ago
UNCY
Premium
The Fly
Unicycive presents on development progress of oxylanthanum carbonate
7M ago
UNCY
Premium
The Fly
Unicycive Therapeutics completes UNI-494 Phase 1 study
7M ago
UNCY
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.